You et al. found in a study on drug resistance mechanisms in lung cancer that crizotinib induced cytoprotective autophagy by inhibiting STAT3 expression in lung cancer cells, which led to the development of drug resistance (You et al., 2015b). Here, STAT3 is linked to lung cancer.